학술논문

101 - Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Document Type
Abstract
Source
In Leukemia Research April 2017 55 Supplement 1:S64-S64
Subject
Language
ISSN
0145-2126